NEW YORK (GenomeWeb) - Sysmex today announced that it has partnered with Singapore-based Clearbridge BioMedics to jointly develop a new liquid biopsy system.

The partners will utilize Clearbridge's microfluidics-based rare cell separation technology, with the goal of potentially creating a new product line to complement Sysmex's current suite of hematology analyzers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.